Novartis loses initial bid to block generic of best-selling heart drug

Novartis failed to persuade a federal court to bar generics maker MSN Pharmaceuticals from marketing its own version of Entresto, Novartis' favoured drug, according to a court ruling on Monday.

Continuar leyendoNovartis loses initial bid to block generic of best-selling heart drug

Biden has allocated $150 million to fight tumours as part of the Cancer Moonshot programme

President Joe Biden on Tuesday will announce $150 million in new federal funding to develop technology to help surgeons successfully remove cancerous tumours, the White House said.

Continuar leyendoBiden has allocated $150 million to fight tumours as part of the Cancer Moonshot programme

J&J received sufficient support from plaintiffs for $6.5bn talc settlement

Johnson & Johnson has crossed a key threshold of support for its proposed $6.5 billion settlement of tens of thousands of lawsuits alleging that its baby powder and other talc-based…

Continuar leyendoJ&J received sufficient support from plaintiffs for $6.5bn talc settlement